Hao Wang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Percutaneous Coronary Intervention

Catheter Ablation

Top Venues

Cardiovascular therapeutics

Reviews in cardiovascular medicine

Molecular genetics & genomic medicine

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yunfei Gu, Hao Wang, Guohua Xue, Yubing Guo, Pengyu Wu, Jingchao He, Aolin Ding, Songsen Li, Gary Tse, Tong Liu
Left Atrial Electrophysiological Properties after Pulmonary Vein Isolation Predict the Recurrence of Atrial Fibrillation: A Cohort Study. Reviews in cardiovascular medicine 25 (5) (2024)
Yunfei Gu, Hao Wang, Guohua Xue, Yubing Guo, Pengyu Wu, Jingchao He, Aolin Ding, Songsen Li, Gary Tse, Tong Liu
Left Atrial Electrophysiological Properties after Pulmonary Vein Isolation Predict the Recurrence of Atrial Fibrillation: A Cohort Study. Reviews in cardiovascular medicine 25 (5) (2024)
Hao Wang, Xiaochun Qing, Hua Wang, Yunfei Gu
Association between Platelet to Neutrophil Ratio (PNR) and Clinical Outcomes in STEMI Patients after Successful pPCI: A Secondary Analysis Based on a Cohort Study. Cardiovascular therapeutics 2022 (2022)
Hao Wang, Lixia Li, Xiaochun Qing, Shouyan Zhang, Shulong Li
Efficacy of Qishen Yiqi Drop Pill for Chronic Heart Failure: An Updated Meta-Analysis of 85 Studies. Cardiovascular therapeutics 2020 (2020)
Hao Wang, Jielin Liu, Kuo Liu, Ya Liu, Jie Wen, Zuoguang Wang, Shaojun Wen
Association of ECE1 gene polymorphisms and essential hypertension risk in the Northern Han Chinese: A case-control study. Molecular genetics & genomic medicine 8 (4) (2020)
Shouyan Zhang, Hao Wang, Lixia Li, Xuewei Chang, Huifang Ma, Mingming Zhang, Xiaochun Qing, Lijun Zhang, Zhuo Zhang
Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose-induced injury in cardiomyocytes. Journal of cellular and molecular medicine 23 (9) (2019)